Articles tagged with Depression
Research using proton magnetic resonance spectroscopy found reduced cortical GABA levels and increased glutamate in melancholic depression patients, a subset of major depressive disorder. The study adds to evidence suggesting both GABA and glutamate systems contribute to mood disorders' pathophysiology.
Researchers found a 31% greater number of nerve cells in the thalamus involved with emotional regulation, leading to physical enlargement and structural abnormalities in individuals with severe depression. The study suggests that brain development abnormalities are responsible for depression.
Three Yale researchers have been awarded grants from the Donaghue Women's Health Investigator Program to explore postpartum depression and hereditary hemorrhagic telangiectasia. These studies aim to improve treatment strategies and outcomes for women, with a focus on sex differences in health and disease.
Women with PTSD experience more medical conditions and poorer physical health compared to those with depression or no history of mental health issues. The study found that PTSD affects 17% of women under 45, while depression rates are higher in older age groups.
A national health survey found that depression in young women is associated with an increased risk of developing the metabolic syndrome, a cluster of factors linked to heart disease. The study also suggests that depression can cause physiological changes that increase the risk of heart disease.
The BOLDER trial found SEROQUEL significantly reduces anxiety symptoms in bipolar depression patients within the first week of treatment. It also improves depressive symptoms and is well-tolerated with a favorable side effect profile.
A new study will evaluate the effectiveness of a face-to-face support group for older adults with depression and HIV/AIDS. The intervention aims to improve coping mechanisms, quality of life, and social support.
A study found that childhood conduct problems predict depression, violence, and social phobia in young adults. Early conduct problems were a strong predictor of later violence, with children three and a half times more likely to engage in violent behavior.
The BOLDER study found SEROQUEL to be superior to placebo in reducing depressive symptoms and anxiety in patients with bipolar disorder. Approximately 50% of patients achieved remission from their bipolar depression symptoms.
A randomized trial of 542 patients with bipolar depression found Seroquel (quetiapine fumarate) to be effective in reducing symptoms, with a response rate of 50% compared to placebo. The study suggests that Seroquel may be a viable treatment option for bipolar disorder, particularly for patients who exhibit anxiety and agitation.
A study of 1,248 people with depression found that those who didn't recover from symptoms after routine treatment were more likely to experience persistent depression and report side effects from medication. These individuals often felt they received inadequate care from their doctors, leading to continued use of healthcare services.
A NIH study found that combination therapy of psychotherapy and pharmacotherapy improved treatment adherence and reduced depression in injection drug users. The study showed nearly 40% of participants fully adherent to treatment were in remission, compared to 12% without treatment.
A study published in the American Journal of Psychiatry found that enhanced counseling, including individual and family therapy, reduced symptoms of depression among caregivers of loved ones with Alzheimer's disease. After one year, 29.8% of caregivers in the enhanced group showed significant improvement.
A recent study published in the American Journal of Psychiatry found that moderately depressed seniors require significantly more hours of care than those without symptoms. If caregivers were paid for their work, the annual cost would be approximately $9 billion, highlighting the impact of depression on seniors and their loved ones.
A study of nearly 3,300 subjects found that any level of depressed mood was associated with a 40% higher risk for stroke among the entire cohort. In contrast, among white subjects, greater severity of symptoms more than doubled the risk of stroke.
A study analyzing published and unpublished trials found that most SSRI antidepressants pose a higher risk than benefits in treating childhood depression. The analysis highlights the need for greater access to unpublished data from the pharmaceutical industry to ensure accurate treatment guidelines.
Concussions are linked to depression and confusion in athletes after injury. The study found that emotional changes disappeared within three weeks of recovery.
A randomized controlled trial found that a home-based program, PEARLS, significantly improved depressive symptoms and health-related quality of life in medically ill, low-income, mostly homebound older adults. The study showed promising results for non-pharmacological treatments in this vulnerable population.
Research links severe atherosclerosis to increased prevalence of depressive disorders in older adults. Patients with coronary and aortic calcifications are at higher risk of developing depressive symptoms.
A study by Express Scripts found that antidepressant use increased significantly among children and adolescents between 1998 and 2002. The fastest-growing segment was preschoolers aged 0-5 years, with use doubling in girls and growing by 64% in boys.
Researchers found that depression is often associated with an underlying autoimmune process affecting the thyroid gland. The study used thyroid function indicators to predict patients' responsiveness to antidepressants, achieving an almost 90% success rate.
A twin study found a possible connection between depression and heart disease, with decreased heart rate variability (HRV) being a key factor. The study suggests that treating clinical depression, including minor forms, may help reduce the risk of heart disease by normalizing HRV.
Researchers at Duke University Medical Center found that women with coronary artery disease are twice as likely to die if they exhibit symptoms of depression. The study analyzed the Beck Depression Inventory scores of 265 women admitted for a diagnostic cardiac catheterization and followed them for up to 3.5 years.
A study found that care managers can significantly improve clinical outcomes for patients with depression, reducing suicidal thoughts and improving treatment response rates. The intervention, which involved structured treatment guidelines and regular follow-up, led to faster resolution of suicidal thinking in patients who received it.
Recent studies suggest that selective serotonin reuptake inhibitors (SSRIs) may be effective in treating social anxiety in alcohol-dependent individuals, particularly those with severe depression. Additionally, anticonvulsants like sodium valproate and atypical antipsychotics like clozapine show promise in reducing alcohol use among bi...
Researchers present findings on various stroke treatments, including the effectiveness of IV magnesium in reducing death and improving functional outcome. Additionally, studies show promise for statins, oxygen therapy, and clot-busting therapies in improving neurological outcomes after ischemic stroke.
A recent study found that 25% of teenage girls experience major depression, highlighting the need for earlier identification and treatment. Decreases in social support and increases in smoking were linked to increased depressive symptoms.
A study of 278 men aged 45+ without depression found that low testosterone levels were associated with a higher incidence of diagnosed depression. Men with hypogonadism were 4.2 times more likely to be diagnosed with depression than those with normal testosterone levels.
UT Southwestern researchers are studying the effect of supervised exercise on individuals taking SSRIs, with preliminary results indicating positive responses from patients. The goal is to determine if exercise can augment SSRI treatment and reduce all symptoms of depression.
A new study found that men who have sex with men experience depression at a rate three times higher than the general population. The issues related to homophobia were strongly predictive of depression among MSM, suggesting a direct link between social attitudes and mental health outcomes.
A clinical trial found that depression improved in most patients after three months of drug therapy, but 24% persisted with high scores. Moderate to severe pain at the start of treatment was associated with a higher risk of poor response.
Researchers found that adolescents with early onset depression had significantly smaller left hippocampuses compared to healthy controls. The study also revealed that those with longer histories of depression had larger hippocampuses, suggesting that initial differences may not be apparent in adult patients.
Postnatal depression is a severe mental illness with long-term effects, responding to treatment and requiring multidisciplinary care. The Lancet article shares a personal account and highlights the importance of recognition, support groups, and medical community response.
A study of 18,980 adults found that morning headaches were associated with depression, anxiety disorders, and other conditions, including sleep-related breathing disorders and musculoskeletal diseases.
Researchers found that cognitive behavioral therapy targets limbic and cortical regions in a distinct pattern from drug therapy, which changes chemical balance in the brain. The study suggests that brain scans may one day help doctors determine the most effective treatment for patients with depression.
A study of 91 patients with traumatic brain injury (TBI) found that depression was a common complication, affecting 33% during the first year. TBI patients with depression were also more likely to have mood and anxiety disorders, exhibiting aggressive behavior and reduced social functioning.
A new study has found that the starting dose of Lexapro is as effective as an optimally dosed Zoloft in treating depression. Patients treated with Lexapro experienced significant relief from depressive symptoms, with 75% achieving a 50% or better reduction in their Montgomery-Asberg Depression Rating Scale scores.
A cross-sectional survey of over 2000 users of Internet depression communities found that major depression was most common in the UK and Sweden, with significant numbers not receiving treatment. The study also showed that online communities can reduce feelings of isolation and lead to seeking professional help.
Researchers found a positive association between high vitamin B12 levels and effective treatment of major depressive disorder. Patients with higher vitamin B12 concentrations responded better to treatment, even when other factors were controlled for.
A new study suggests that caregivers of patients with end-of-life dementia experience high levels of depressive symptoms while caring for their loved ones, but exhibit clinically lower depression after the patient's death. The research also found that caregivers report feeling relieved when their loved one passes away.
A Stanford study found that 18% of Europeans with depressive disorder also had a breathing-related sleep disorder, which can increase the risk of feeling sleepy and irritable. The study suggests that treating sleep apnea may help control depression in patients.
A recent study published in the American Journal of Public Health found that major depression was most prevalent among Hispanics, followed by African Americans and whites. The odds of depressive disorders were significantly higher among older Hispanics due to caregiving responsibilities.
A study found that children whose mothers experience postnatal depression are more likely to exhibit violent behavior, particularly in boys. The link is associated with attention and emotional regulation problems, which can lead to a higher propensity for violence.
A study of 73 patients with traumatic injuries found that those with depression and PTSD reported higher levels of physical distress. Women were more likely than men to experience such symptoms, highlighting the importance of early mental health screening and intervention.
A study by Ohio State University researchers found that even mild depression in caregivers can lead to increased inflammation, which is associated with various age-related illnesses. Chronic inflammation has been linked to declines in physical function and an increased risk of mortality.
A new Duke study finds that forgiveness, through loving-kindness meditation, reduces back pain and depression in patients with persistent low back pain. The study suggests a strong relationship between forgiveness and pain, including measures of adjustment.
A pioneering study using brain imaging has yielded new insights into treatment-resistant depression, revealing differences in brain activity between healthy individuals and those suffering from the condition. The research also highlights the potential for developing a new generation of antidepressants with unprecedented efficacy.
The study found that nearly 68% of patients who received antidepressant treatment were alive after nine years, compared to about 36% of those who received placebo. The researchers believe antidepressants may provide protective effects by improving recovery and reducing mortality in stroke patients.
A Stanford study found that a skill-building program significantly reduced depression, anxiety, and frustration among female caregivers. The program, which focuses on increasing self-efficacy and problem-solving skills, was more effective than traditional support groups in improving caregiver outcomes.
A new study has found that a phone support group program helps older adults with HIV/AIDS develop coping skills, reducing stress and suicidal thoughts. The 12-week telephone intervention program appealed to participants who faced barriers in accessing traditional support groups or counseling services.
A controlled study after the Dutch café fire found a 75% increase in clinical overall mental-health symptom scores among Volendam adolescents compared to other students. These scores were significantly higher for girls than boys, indicating that post-disaster healthcare should focus on psychosocial consequences.
Research shows a shift toward 'medicalization' of deviation from women's traditional roles, while men's depressive illness is increasingly described in terms connoting work and aggression. The study highlights the importance of accurate media representation in influencing patient-doctor communication about mental health concerns.
Young adults who experienced major depressive disorder during adolescence showed pervasive impairments by mid-20s. They struggled with work performance, social difficulties, and low physical well-being. The study emphasizes the importance of preventing depression in adolescence through effective interventions.
Researchers at Duke University Medical Center found that depression is a strong independent risk factor for death in patients undergoing coronary artery bypass surgery. Depression was associated with a doubling of the risk of death during the follow-up period, regardless of other factors.
Researchers found that antidepressant treatment appears to preserve hippocampal volumes in depressed patients, compared to those who have not taken medication. The study suggests that using antidepressants whenever symptoms occur may help prevent long-term brain damage.
A three-year study of 193 healthy older adults found that social environment, including home and family, was the most important factor in determining quality of life. Good mental faculties and personal optimism also played a significant role.
Researchers found a strong association between increased hostility and depressive symptoms and elevated IL-6 levels in healthy men. These findings suggest that psychological factors may contribute to the development of heart disease through inflammation. Further studies are underway to investigate this relationship in women.
A recent study found that symptoms of depression are a consistent predictor of shortened survival in cancer patients. After accounting for other factors, researchers discovered that depressive symptoms were the most significant psychological indicator of poor outcomes.
A study led by Constantine Lyketsos found that sertraline hydrochloride significantly improved the quality of life and reduced functional decline in Alzheimer's patients with depression. The treatment showed a positive influence on 84% of participants, while only 35% in the placebo group experienced improvements.
Researchers found that a specific gene variant interacts with stressful events to predict depression risk, with individuals carrying a short allele more vulnerable to depression after stress. The study's findings suggest new potential treatments and diagnostic techniques for millions of people worldwide affected by depression.